Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

DNA methylation haplotypes as cancer markers

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Distribution of the estimated whole blood cfDNA proportions in normal, colorectal cancer and lung cancer plasma.

References

  1. Guo, S. et al. Nat. Genet. 49, 635–642 (2017).

    Article  CAS  Google Scholar 

  2. Sun, K. et al. Proc. Natl. Acad. Sci. USA 112, E5503–E5512 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John M. Greally.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seoighe, C., Tosh, N.J. & Greally, J.M. DNA methylation haplotypes as cancer markers. Nat Genet 50, 1062–1063 (2018). https://doi.org/10.1038/s41588-018-0185-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-018-0185-x

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer